Journal of Advanced Pharmaceutical Technology & Research Vol.

1 (1), Jan-Mar, 2010

ISSN 0976-2094

TROUBLE SHOOTING DURING BIOANALYTICAL ESTIMATION OF DRUG AND METABOLITES USING LC-MS/MS: A REVIEW Ganesh N. Sharma*1, Man Mohan Singhal1, K.K.Sharma2, Jyotsana Sanadya 3
1. School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, (India) 2. LBS College of Pharmacy, Tilak Nagar, Jaipur, Rajasthan, (India) 3. Maharishi Arvind Institute of Pharmacy, Mansarovar, Jaipur, Rajasthan, (India) Corresponding Authors E-mail: - ganeshmph@gmail.com Received: 08th January 2010 Revised: 11th February 2010 Accepted: 01st March 2010

Abstract
Bioanalysis frequently involves the measurement of very low analyte concentrations in complex and potentially variable matrices. An initial attempt has been made to apply a risk management tool to the bioanalytical method development like selection of spiked plasma volume, selection of internal standard to minimize processing error, selection of medium and extraction procedure, setting of mobile phase and pH, determination of chromatographic conditions etc. and to minimize instrumental error like; ion suppression and matrix effect.

Key Words: Bioanalysis, LC-MS/MS, Ion suppression, Matrix effect.

Introduction
The pharmacological response is generally related to the concentration of drug at receptor site [1] and the availability of a drug from a dosage form is a critical element of drug efficacy [2]. However; drug

concentration in the biological matrix [3] like blood, plasma, urine etc. This is based on the premise that the drug at site of action is in equilibrium with drug in blood. It is therefore possible to obtain an indirect measure of drug response by monitoring drug level in biological matrix. The bio-analysis is employed for the quantitative determination of drug &

concentrations usually, cannot be readily measured directly at the site of action, therefore most bioavailability (BA) studies involve the determination of drug

metabolites in biological fluids play a 1

Available online on www.japtr.org

Journal of Advanced Pharmaceutical Technology & Research Vol. 1 (1), Jan-Mar, 2010

ISSN 0976-2094

significant

role

in

evaluation

of

significant role in evaluation of BE, Pharmacokinetic (PK) and toxicological studies. It is the way of comparative studies between two or more formulations of the similar drug products.

bioequivalence (BE), pharmacokinetic (PK) and toxicological studies. It is the way of comparative studies between two or more formulations of the similar drug products. One of the recent important instrumental developments, giving high selectivity and sensitivity for complex samples, is the hyphenation of liquid chromatography

Applications of bioanalysis
1. To identify and /or quantify illicit drugs in biological samples for the detection of substances of abuse 2. To assay foreign substances in biological materials, sometime postmortem for evidence of poison in toxicological and forensic use. 3. To analyze trace elements and toxic substances in natural science and

(HPLC) with mass spectrometry (MS) [4] i.e. LC-MS or MS is combination of high performance liquid chromatography (HPLC). Chromatography is a non-destructive procedure for resolving a multi component mixture of trace, minor or major constituent into its individual fractions. This may be applied both quantitatively and qualitatively. LC-MS/MS is the best method, when the detector has to be more sensitive, more specific or unknowns have to be identified [5]. An advantage is that, at least for some of the LC-MS / MS techniques, the development of a method needs no compromise for adaptation to MS; drawbacks are such as the added degree of complexity in instrumentation and, in studies requiring precise quantitative work, the need for internal standards [6].

environmental research. 4. To monitor the concentration of drugs and metabolites in tissues, blood,

plasma, serum and urine specimens for a better understanding of the

pharmacology and toxicity of drugs. 5. To apply therapeutic drug monitoring in the management of the drug treatment in patients.

LC-MS/MS
Liquid chromatography and mass spectrometry is two segment of a LCMS/MS system. The sample under

Bioanalysis
Bioanalysis quantitative is employed of for drug the & determination

investigation has to be introduced into the ionisation source of the instrument. Inside the ionisation source, sample molecules are 2

metabolites in biological fluids play a

Available online on www.japtr.org

Journal of Advanced Pharmaceutical Technology & Research Vol. 1 (1), Jan-Mar, 2010

ISSN 0976-2094

ionised.

These ions are extracted into the

that are separated or filtered on the basis of their mass to charge ratio (m / z). [9] Structural information can be generated using certain types of mass spectrometers, usually tandem mass spectrometers, and this is achieved by fragmenting the sample and analysing the products generated.

analyser region of the mass spectrometer where they are separated according to their mass (m) to charge (z) ratios (m/z). The

separated ions are detected and this signal sent to a data system where the m/z ratios are stored together with their relative abundance for presentation in the format of an m/z spectrum.

CHROMATOGRAPHY
Chromatography is a non-destructive procedure for resolving a multi component mixture of trace, minor or major constituent into its individual fractions. This may be applied both quantitatively and qualitatively.

High

performance

liquid

chromatography
HPLC is an analytical technique for the separation and determination of organic and inorganic solutes in any sample, Figure.1: Components of an LC system. Tandem (MS-MS) mass

especially biological, pharmaceutical, food, environmental, and industrial. [7] HPLC is more versatile since it is not limited to volatile and thermally stable samples, and the choice of mobile phase and stationary phase is wider.[8]

spectrometers are instruments that have more than one analyser and so can be used for structural and sequencing studies. Two, three and four analysers have all been incorporated into commercially available tandem instruments, and the analysers do not necessarily have to be of the same type, in which case the instrument is a hybrid one. More popular tandem mass spectrometers include those of the quadrupole-quadrupole, 3

Mass Spectrometry
Mass spectrometers are an analytical tool used for measuring the molecular weight (MW) of a sample. The principal of MS is the production of ions from analysed compounds

Available online on www.japtr.org

Journal of Advanced Pharmaceutical Technology & Research Vol. 1 (1), Jan-Mar, 2010

ISSN 0976-2094

magnetic recently,

sector-quadrupole, the

and

more

Critical points in bioanalysis with LC-MS/MS

In order to determine the accurate concentration of drug and metabolites in biological challenges. overall matrix there are so many

quadruple-time-of-flight

geometries. [10]

These challenges make the difficult. The major

process

challenges are as: What would be the exact

chromatographic conditions including selection of column, mobile phase, flow conditions, sample preparation method and detection system? Is the developed method precise,

accurate and reproducible? Is it robust Figure.2 Typical flow diagram of a Mass Spectrometer with regard to column, machine and analyst? To solve these problems, we have to validate [11] the developed method with regard to both the parent drug and metabolite.

Development of analytical method

Development of a suitable method for analysis of drug is the most important step in analytical studies, since the behavior of the drugs in biological matrixes depends on the levels of interferences that interact with the active molecule. Another aspect to be highlighted is the change of the Figure.3 Typical LC-MS/MS configuration components of the biological matrix subject to storage, process, taking into consideration time and temperature.
Available online on www.japtr.org

Thus degradation 4

Journal of Advanced Pharmaceutical Technology & Research Vol. 1 (1), Jan-Mar, 2010

ISSN 0976-2094

products, complexing, oxidation, metabolites and other substances change the response of a method if this is not sufficiently selective for the studies with fresh and aged biological matrixes. An idea regarding the method to be used for analysis, we can obtain from the various available research papers, literature survey etc. Literature surveys should be made with regard to following in mind: I. Maximum plasma concentration (Cmax) of the drug and metabolite: knowing Cmax helps the establishment of target sensitivity of method. II. Physiochemical properties of the drug and metabolite: following properties aid to guess and select proper extraction and sample preparation procedure. a) Molecular weight (MW) b) Solubility c) Structure d) Dissociation constant (pKa) e) Melting point.

we prepare standard workings stock solution (main stock) of highest and lowest

concentration. Now from these main stocks, we prepare different solutions of

intermediate concentration.

Setting of mobile phase

A successful chromatographic separation depends upon differences in the interaction of the solutes with the mobile phase and the stationary phase, and in liquid chromatography, choice and variation of the mobile phase is of critical importance in achieving optimum efficiency.

Establishment procedure

of

extraction

I. Physiochemical property of drugs II. Selection of solvent for extraction: A good solvent contains following

characteristics: Drug should be soluble properly in the solvent. It should not be flammable and hazardous. It should be easily available and should not be of high cost. It should be easily evaporated, so that drug can be re-obtained from the solution. III. Selection of medium (acidic/ basic or neutral)

Determination of lower and upper limit of quantification

The lowest concentration of an analyte or lower limit of quantification (LLOQ) in a sample that can be quantitatively determined with an acceptable precision and accuracy is usually 1/20th of the Cmax value. After

calculating the ULOQ and LLOQ values [12]

Available online on www.japtr.org

Journal of Advanced Pharmaceutical Technology & Research Vol. 1 (1), Jan-Mar, 2010

ISSN 0976-2094

IV. Selection of extraction procedure i.e. either liquid-liquid extraction (LLE), protein

interfere in the analysis. Internal standard should be chemically and physically similar with the drug, as well as it should not have any chemical reaction with drug and should be of high purity. Generally, internal standard is selected, from the same category of the drug. For example; In the case of Losartan and Losartan Carboxylic Acid bioanalytical study, valsartan may be used as the internal standard.

precipitation (PP), or solid phase extraction (SPE).

Selection of plasma volume spiked

Minimum plasma volume which provided sufficient recovery of both drug and the metabolite is used in plasma blank sample. Recovery of drug and calculated by the formula; Mean peak response (Extracted sample) % recovery = _______________ x 100 metabolites are

Optimization of matrix effect

The US-FDA guidance for industry on bioanalytical method validation requires the assessment of matrix effect during

Mean peak response (Un-extracted sample)

method

validation

for

quantitative

bioanalytical LC-MS/MS methods. A matrix effect [13] is defined as the analyte

Selection of drug and metabolite volume to spike

The volume of drug and metabolite to be added depend upon the volume of plasma spiked. Drug and metabolite concentration is normally 5 % of the spiked plasma volume. For example, if the spiked plasma volume is 500 l, so the volume of drug and metabolite to be added will be 25l of each.

ionization suppression or enhancement at the presence of the matrix components that could originated from the endogenous compounds, metabolites and co-

administered drugs. More recently matrix effects from internally standard dosing vehicle and mobile phase additives and plastic tubes also reported. This step is usually necessary to remove matrix components such as proteins, salts and other organic compounds in biological matrices which otherwise may impose interferences or ionization

Selection of internal standard

To determine whether the sample prepared is with least error, internal standard is added in plasma. Internal standard is the, compound of known purity, which, it does not

suppressions to the analytes. 6

Available online on www.japtr.org

Journal of Advanced Pharmaceutical Technology & Research Vol. 1 (1), Jan-Mar, 2010

ISSN 0976-2094

Ion suppression
Ion suppression coupled in with liquid mass chromatography

difference in response now could be considered caused by extraction recovery.

Chromatographic determination

condition

spectrometry (LC-MS/MS) can occur, when a co-eluted compound suppresses the ionization of the sample molecules in a mass

Another important aspects with LCMS/MS use for bioanalysis of drug and metabolites are determination of exact conditions including

spectrometers source. This ion suppression is analogous to the large garbage peak for unretained material common at the beginning of chromatograms Ion monitored by like UV other

chromatographic selection of

column,

flow conditions,

detection system probe position, mode of pump, injection volume etc. For Example: Poor analyte column retention may result in detrimental matrix effect that has been identified as one of the major reasons why bioanalytical LC-MS/MS method fails.

detection.

suppression,

chromatographic interferences, compromises quantitative analysis because it can vary from sample to sample. To solve this problem one approach is to post column infusion of an analyte into the MS detector. The purpose of post column infusion with the analyte is to raise the background level so that the suppression matrix will show as negative peak. Any deviation from the baseline caused by injecting the matrix blank indicates the existing of matrix effect. Similarly, the recovery is determined by comparing the MS response of extracted sample with those spiked (post extraction) into a blank matrix. Because both samples have the matrix ingredients present, the matrix effect can be considered the same for extracted sample and post extracted sample. Any

Conclusion
In order to determine the accurate concentrations of drug and metabolites in biological matrix by using LC-MS/MS, there are many challenges. The major challenges are, establishment of suitable sample preparation technique, setting of instrumental parameters such as, flow rate, probe position, injection volume, mobile phase determination etc. But at the same time, we should be careful for the system also as the impurity of sample (For example; some time sample prepared by the protein precipitation technique remain with large particle size can chock the column and increases pressure of the system), pH of the

Available online on www.japtr.org

Journal of Advanced Pharmaceutical Technology & Research Vol. 1 (1), Jan-Mar, 2010

ISSN 0976-2094

mobile phase (very low pH solvent may degrade the column) etc. may harm the system.

5. Liquid

Chromatography Applications Pharmaceutical Chemistry, ACS Syrnp.

Mass in and (M.A. Ser.,

Spectrometry Agricultural, Environmental Brown, ed.)

References
1. Food and Drug Administration. (Draft) Guidance for Industry: BA and BE Studies for Orally Administered Drug ProductsGeneral Considerations Rock-ville, MD: US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research; 1999., pp1-14. 2. Guidelines for bioavailabity and

Washington (1990), 1914-1926. 6. Wieling J., with LC-MS-MS internal experiences standards

Chromatographia 113.

2002, 55, pp. S.107-

7. Breda, M. Marrari, R. Pianezzola, E. Strolin Benedetti, M., Determination of ethambutol in human plasma and urine by high-performance with liquid fluorescence

bioequivalence

studies, central drug

standard control organisation, directorate general of health services ministry of health and family walfare, govt. of India, new delhi, march 2005, pp.1-34s. 3. Preliminary Draft Guidance for Industry on in-vivo Bioequivalence Studies Based on Population and Individual

chromatography

detection Journal of Chromatography A, 1996, 729(1-2), pp. 301-307. 8. Henk A Characterization of stationary phases for reversed-phase column liquid testing,

chromatography:

classification and chemical stability Technische 1999, 7-8. 9. Siri, William, "Mass spectroscope for analysis in the low-mass range", Review of Scientific Instruments, 1947, 18 (8): pp. 540545. 10. Weinmann W.; Gergov M.; Goerner M. MS/MS-libraries with triple Universiteit Eindhoven,

Bioequivalence Approaches: Availability, The Food and Drug Administration

(FDA), 1997, (62), pp 249. 4. Ran Yin, Xiaohui Chen, Fei Han, et.al;

LC-MS

Determination

and

Pharmacokinetic Study of Luteolin-7- O -D -glucoside in Rat Plasma after Administration of the Traditional Chinese Medicinal Preparation Kudiezi Injection Chromatographia, 2008 (67), pp.961-965.

quadrupole-tandem mass spectrometers for drug identification and drug 8

Available online on www.japtr.org

Journal of Advanced Pharmaceutical Technology & Research Vol. 1 (1), Jan-Mar, 2010

ISSN 0976-2094

screening: Structure elucidation by LCMS 2000 (20), pp. 934- 941. 11. Guidance for Industry, Bioanalytical

Validation and Implementation: Best Practices for Chromatographic and

Ligand Binding Assays AAPS Journal, 2007; 9. 13. Vladimr Capka, and Spencer J. Carter Minimizing matrix effects in the

Method Validation U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), May 2001, BP., pp1-25. 12. Viswanathan CT, Bansal S, Booth B, et. al.; Workshop/Conference Quantitative Bioanalytical Report -

development of a method for the determination of salmeterol in human plasma by LC/MS/MS at low pg/mL concentration Chromatography 2007 (856), pp levels Journal of B, 285-293.

Methods

Available online on www.japtr.org

Journal of Advanced Pharmaceutical Technology & Research Vol. 1 (1), Jan-Mar, 2010

ISSN 0976-2094

Source of support: Nil, Conflict of interest: None Declared

Available online on www.japtr.org

10